Ketamine is the only legally available medicine with psychoactive to psychedelic properties. The Ketamine Research Foundation stands at the center of ketamine research, training, and psychotherapy.
We advance the use of Ketamine in therapeutic methodologies and practices to promote the well-being and balance of our patients through the application of Ketamine Assisted Psychotherapy (KAP).
Our commitment to streamlined and creative research, guided by appropriate safeguards and IRB approvals is unrivaled – all the while setting a gold standard for therapeutics, accountability, accessibility to care, education, and above all, comprehensive training.
We are the ground upon which assisted psychotherapy practices develop and mature with a priority to position the ethical and therapeutic uses of ketamine as the first alternative in the medical toolbox. The wide spectrum of programs that are part of the Ketamine Research Foundation exemplifies our dedication to collaboration, an international presence, and the fulfillment of ketamine’s promise as an extraordinary agent of change and growth.
KRF is building a crucial foundation of experienced practitioners and methods for psychedelic psychotherapy and its future as a healing practice:
KRF’s research initiatives are at the center of growing support for ketamine-based therapies among consumers, legislators, and the medical community. We are the established leader in the clinical research of Ketamine Assisted Psychotherapy and its applications including:
The coalition is an international trauma treatment program that uses Sharing Groups as a model for bringing together individuals who have experienced trauma. These struggles can include loss, illness, climate disaster, addiction, and stress, all talked through in a compassionate and supportive environment.
The coalition offers group therapy sessions that are open to members and financially supported by KRF.